We are pleased to announce that DiveRadGel has been selected for the “UNIKORN” a startup support program organized by LINK-J in Japan, following a competitive application and pitch screening process.Through this program, we will fully leverage the support provided to accelerate our DRG cancer vaccine development program and expand into the UK and European markets.
関連記事
DiveRadGel Initiates Collaborative Research with Division of CancerImmunology, Graduate School of Medical and Dental Sciences, NiigataUniversity, to Develop an Off-the-shelf Cancer Vaccine Based on SharedNeoantigens
Announcement of Company Establishment
DiveRadGel is Exhibiting at BIO International Convention 2025
新潟大学大学院医歯学総合研究科がん免疫学分野との、共通ネオアンチゲンを用いたオフ・ザ・シェルフ型がんワクチンの開発に関する共同研究開始のお知らせ
Featured in Nihon Keizai Newspaper.
AMED「ニューモダリティコンソーシアム」入会承認のお知らせ